Skip to main content

Market Overview

Why Stellar Biotech Shares Are Up 70%

Why Stellar Biotech Shares Are Up 70%

Stellar Biotech (NASDAQ: SBOT) shares were up more than 70 percent Friday morning following an 8-K filing late Thursday disclosing its board and Edesa Biotech approved a transaction that was originally disclosed on March 8.

During the fiscal second quarter, Stellar Biotech entered into a share exchange agreement with Edesa Biotech, a Canadian biopharmaceutical company. Under the terms of the agreement, Edesa Biotech shareholders agreed to exchange their shares of Edesa for newly-issued common shares of Stellar.

An 8-K filing is a form used to notify investors in U.S. public companies of specified events that may be important to shareholders.

There has been some extreme volatility in momentum stocks this week. Obalon Therapeutics (NASDAQ: OBLN) shares rose triggered by a questionable rumor, while Soliton Inc (NASDAQ: SOLY) shares have more than tripled since Tuesday.

Stellar Biotech traded around $2.05 per share Friday morning, up 70.8 percent.


Related Articles (SBOT)

View Comments and Join the Discussion!

Posted-In: Edesa BiotechBiotech News Rumors Movers Trading Ideas General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at